SIC
PFE icon

Salem Investment Counselors’s Pfizer PFE Stock Holding History

Salem Investment Counselors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Sell
106,893
-960
-0.9% -$25.1K 0.06% 153
2026
Q1 		$3.03M Sell
107,853
-477
-0.4% -$12.7K 0.09% 125
2025
Q4 		$2.7M Sell
108,330
-2,850
-3% -$71.9K 0.08% 132
2025
Q3 		$2.83M Sell
111,180
-2,972
-3% -$73.4K 0.08% 130
2025
Q2 		$2.77M Sell
114,152
-3,955
-3% -$92.2K 0.09% 129
2025
Q1 		$2.99M Sell
118,107
-7,986
-6% -$209K 0.1% 114
2024
Q4 		$3.35M Sell
126,093
-4,408
-3% -$120K 0.11% 110
2024
Q3 		$3.78M Sell
130,501
-1,381
-1% -$40.3K 0.11% 103
2024
Q2 		$3.69M Sell
131,882
-4,544
-3% -$125K 0.12% 107
2024
Q1 		$3.79M Sell
136,426
-24,295
-15% -$674K 0.12% 108
2023
Q4 		$4.63M Sell
160,721
-39,189
-20% -$1.18M 0.16% 89
2023
Q3 		$6.63M Sell
199,910
-241,261
-55% -$8.53M 0.25% 62
2023
Q2 		$16.2M Sell
441,171
-11,177
-2% -$435K 0.59% 27
2023
Q1 		$18.5M Buy
452,348
+2,085
+0.5% +$90.1K 0.74% 24
2022
Q4 		$23.1M Sell
450,263
-9,260
-2% -$444K 0.99% 15
2022
Q3 		$20.1M Buy
459,523
+31,294
+7% +$1.52M 0.92% 19
2022
Q2 		$22.5M Sell
428,229
-781
-0.2% -$39.8K 1.02% 14
2022
Q1 		$22.2M Buy
429,010
+15,545
+4% +$807K 0.87% 16
2021
Q4 		$24.4M Buy
413,465
+4,641
+1% +$230K 0.85% 18
2021
Q3 		$17.6M Buy
408,824
+13,872
+4% +$615K 0.96% 24
2021
Q2 		$15.5M Buy
394,952
+10,337
+3% +$402K 0.85% 29
2021
Q1 		$13.9M Buy
384,615
+36,707
+11% +$1.3M 0.85% 29
2020
Q4 		$12.8M Buy
347,908
+16,040
+5% +$588K 0.84% 30
2020
Q3 		$11.6M Buy
331,868
+36,145
+12% +$1.27M 0.88% 29
2020
Q2 		$9.18M Buy
295,723
+36,835
+14% +$1.25M 0.78% 33
2020
Q1 		$8.02M Sell
258,888
-15,801
-6% -$538K 0.83% 30
2019
Q4 		$10.2M Buy
274,689
+1,627
+0.6% +$58K 0.85% 29
2019
Q3 		$9.31M Sell
273,062
-416
-0.2% -$15.1K 0.86% 28
2019
Q2 		$11.2M Sell
273,478
-1,158
-0.4% -$46K 1.04% 25
2019
Q1 		$11.5M Buy
274,636
+5,345
+2% +$214K 1.17% 25
2018
Q4 		$11.2M Sell
269,291
-5,345
-2% -$222K 1.4% 20
2018
Q3 		$11.5M Sell
274,636
-20,620
-7% -$794K 1.17% 25
2018
Q2 		$10.2M Sell
295,256
-8,699
-3% -$297K 0.93% 24
2018
Q1 		$10.3M Sell
303,955
-9,934
-3% -$342K 1.16% 26
2017
Q4 		$10.8M Buy
313,889
+2,245
+0.7% +$76.5K 1.17% 24
2017
Q3 		$10.6M Sell
311,644
-12,358
-4% -$397K 1.24% 22
2017
Q2 		$10.3M Buy
324,002
+12,758
+4% +$402K 1.2% 25
2017
Q1 		$10.1M Sell
311,244
-40,202
-11% -$1.27M 1.08% 31
2016
Q4 		$10.8M Sell
351,446
-50,341
-13% -$1.54M 1.24% 28
2016
Q3 		$129K Buy
401,787
+54,110
+16% +$1.81M 1.69% 15
2016
Q2 		$11.6M Sell
347,677
-7,641
-2% -$244K 1.39% 17
2016
Q1 		$9.99M Sell
355,318
-7,005
-2% -$200K 1.24% 24
2015
Q4 		$11.1M Sell
362,323
-3,652
-1% -$115K 1.4% 19
2015
Q3 		$10.8M Buy
365,975
+5,697
+2% +$183K 1.41% 16
2015
Q2 		$11.5M Sell
360,278
-1,777
-0.5% -$57.9K 1.39% 17
2015
Q1 		$12M Buy
362,055
+665
+0.2% +$21.1K 1.43% 15
2014
Q4 		$10.7M Buy
361,390
+3,900
+1% +$112K 1.27% 19
2014
Q3 		$10M Sell
357,490
-8,500
-2% -$239K 1.2% 20
2014
Q2 		$10.3M Sell
365,990
-5,762
-2% -$164K 1.25% 20
2014
Q1 		$11.3M Sell
371,752
-258
-0.1% -$7.69K 1.4% 19
2013
Q4 		$10.8M Sell
372,010
-7,911
-2% -$230K 1.41% 16
2013
Q3 		$10.4M Sell
379,921
-9,538
-2% -$260K 1.44% 18
2013
Q2 		$10.3M Buy
+389,459
New +$10.8M 1.5% 17

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Salem Investment Counselors's PFE Position: Q2 2026 in Review

Salem Investment Counselors reduced its Pfizer (PFE) stake by 0.89% in Q2 2026, selling an estimated $25.1K and leaving 106,893 shares worth $2.57M. The position accounts for 0.06% of the portfolio, ranked #153.

Salem Investment Counselors first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $24.4M in Q4 2021. 901 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Salem Investment Counselors held 106,893 shares of Pfizer worth $2.57M as of Q2 2026.
  • Salem Investment Counselors sold 960 Pfizer shares in Q2 2026, an estimated $25.1K.
  • Pfizer made up 0.06% of Salem Investment Counselors's portfolio in Q2 2026, its #153 holding.
  • Salem Investment Counselors first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Salem Investment Counselors's Pfizer position peaked at $24.4M in Q4 2021.
  • 901 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.